Telehealth is fastest growing segment fueling the growth of Bispecific Antibodies Market

 

Bispecific antibodies are monoclonal antibodies that have a dual targeting ability to bind two different antigens or epitopes simultaneously. They are used for targeted drug delivery and have advantages of enhanced specificity and efficacy.

The global Bispecific Antibodies Market is estimated to be valued at US$ 41.08 Mn in 2023 and is expected to exhibit a CAGR of 29% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
One of the major trends in the bispecific antibodies market is its rising application in the area of oncology. Bispecific antibodies have shown more effective targeting of tumor cells and better clinical responses in cancer treatment compared to conventional monoclonal antibodies. They can simultaneously bind to tumor antigens and recruit immune cells like T cells or NK cells to the tumor microenvironment, inducing enhanced killing of cancer cells. This has led to ongoing clinical trials and regulatory approvals of several bispecific antibodies for the treatment of different cancer types.
Here is the segment analysis and key takeaways for the given Bispecific Antibodies market:

Segment Analysis
The global bispecific antibodies market is segmented based on product, application, end user, and region. By product, the market is divided into CD19/CD3, CD30/CD16A, and others. The CD19/CD3 segment dominates the market as CD19/CD3 bispecific antibodies are approved for the treatment of various blood cancers such as acute lymphoblastic leukemia and non-Hodgkin’s lymphoma.

Key Takeaways
The global bispecific antibodies market is expected to witness high growth, exhibiting a CAGR of 29% over the forecast period, due to increasing prevalence of cancer worldwide.

Regional analysis
North America holds the major share in the global bispecific antibodies market due to growing advancements in cancer immunotherapy and the increasing demand for targeted cancer therapies in the region. Asia Pacific is expected to grow at the fastest pace during the forecast period owing to improving healthcare infrastructure and rising cancer incidence in developing countries such as India and China.

Key players
Key players operating in the bispecific antibodies market are Amgen, Inc., Bayer AG, Dow Pharmaceutical Solutions, ImmunGene, Inc., Immunocore Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and F. Hoffmann-La Roche AG. Amgen's Blincyto is dominating the market as it is the only FDA-approved CD19/CD3 bispecific antibody for the treatment of acute lymphoblastic leukemia.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more